Insulin Pumps — Global Pipeline Analysis, Opportunity Assessment and
Market Forecasts to 2016
Publication Date: 29 July
2010
Publisher: GlobalData
Pages:
73
|
Single user price: $3,500
Buy
now >>
(managed by GlobalData)
|
Summary
GlobalData’s medical equipment report, “Insulin Pumps – Global
Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016”
provides key data, information and analysis on the global insulin pumps
market. This report provides market landscape, competitive landscape and
market trends information on insulin pumps, a key segment in the
diabetes care devices market. The report provides comprehensive
information on the key trends affecting the market, and key analytical
content on the market dynamics. The report also reviews the competitive
landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house
analysis by GlobalData’s team of industry experts.
Scope
- Key geographies covered include the US (United States), Canada,
the UK (United Kingdom), Germany, France, Italy, Spain, Japan,
China, India, Australia, and Brazil.
- Key segments covered include Disposable Insulin Pumps and
Traditional Insulin Pumps.
- Annualized market revenues data from 2002 to 2009, forecast
forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and
restraints by each category within the insulin pumps market.
- The report also covers information on the leading market
players, the competitive landscape, and the leading pipeline
products and technologies.
- Key players covered include Medtronic, Animas, Smiths Medical,
Roche and Insulet.
Reasons to buy
- Develop business strategies by understanding the trends and
developments that are driving the insulin pumps market globally.
- Design and develop your product development, marketing and sales
strategies.
- Exploit M&A opportunities by identifying market players with the
most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the
emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by
identifying products, most likely to ensure a robust return.
- What’s the next being thing in the insulin pumps market
landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and
in-depth analysis of the global insulin pumps market and the factors
shaping it.
Buy
now >>
(managed by GlobalData)
Table of contents
1 Table of contents 3 1.1 List of Tables 5 1.2 List of Figures
6 2 Introduction: Insulin Pumps 7 2.1 GlobalData Report Guidance 7
3 Disease Overview: Diabetes 8 3.1 Pathophysiology 8 3.2 Signs and
Symptoms 9 3.3 Risk Factors 10 3.4 Diagnosis 10 3.4.1 Finger
Stick Blood Glucose Test: 10 3.4.2 Fasting Plasma Glucose Test: 10
3.4.3 Oral Glucose Tolerance Test: 10 3.4.4 Glycosylated Hemoglobin
or Hemoglobin A1c: 10 3.5 Treatment 11 3.5.1 Diabetes Epidemiology
11 3.5.2 Diabetes Treatment 12 4 Global Insulin Pumps Market
Characterization 15 4.1 Global Insulin Pumps Market, Revenues ($m),
Historic, 2002 – 2009 15 4.2 Global Insulin Pumps Market, Revenues
($m), Forecast, 2009 – 2016 16 4.3 Global Insulin Pumps, Market
Dynamics 17 4.3.1 Insulin Pumps: Market Drivers 17 4.3.2 Insulin
Pumps: Market Restraints 20 5 The Global Insulin Pumps Market: Cross
Country Analysis and Forecasts 23 5.1 Revenue and Revenue Forecast,
By Country 24 5.1.1 US Insulin Pumps market, Revenue ($m), Historic,
2002-2009 24 5.1.2 US Insulin Pumps market, Revenue ($m), Forecast,
2009-2016 25 5.1.3 Canada, Insulin Pumps Market, Revenue ($m),
Historic, 2002-2009 26 5.1.4 Canada Insulin Pumps Market, Revenue
($m), Forecast, 2009-2016 27 5.1.5 Germany, Insulin Pumps Market,
Revenue ($m), Historic, 2002-2009 28 5.1.6 Germany, Insulin Pumps
Market, Revenue ($m), Forecast, 2009-2016 29 5.1.7 France, Insulin
Pumps market, Revenue ($m), Historic, 2002-2009 30 5.1.8 France,
Insulin Pumps Market, Revenue ($m), Forecast, 2009-2016 31 5.1.9
Italy, Insulin Pumps Market, Revenue ($m), Historic, 2002-2009 32
5.1.10 Italy, Insulin Pumps Market, Revenue ($m), Forecast, 2009-2016 33
5.1.11 The UK, Insulin Pumps Market, Revenue ($m), Historic, 2002-2009
34 5.1.12 The UK, Insulin Pumps Market, Revenue ($m), Forecast,
2009-2016 35 5.1.13 Spain, Insulin Pumps Market, Revenue ($m),
Historic, 2002-2009 36 5.1.14 Spain, Insulin Pumps Market, Revenue
($m), Forecast, 2009-2016 37 5.1.15 China, Insulin Pumps Market,
Revenue ($m), Historic, 2002-2009 38 5.1.16 China, Insulin Pumps
Market, Revenue ($m), Forecast, 2009-2016 39 5.1.17 India, Insulin
Pumps Market, Revenue ($m), Historic, 2002-2009 40 5.1.18 India,
Insulin Pumps Market, Revenue ($m), Forecast, 2009-2016 41 5.1.19
Japan, Insulin Pumps Market, Revenue ($m), Historic, 2002-2009 42
5.1.20 Japan, Insulin Pumps Market, Revenue ($m), Forecast, 2009-2016 43
5.1.21 Brazil, Insulin Pumps Market, Revenue ($m), Historic, 2002-2009
44 5.1.22 Brazil, Insulin Pumps Market, Revenue ($m), Forecast,
2009-2016 45 5.1.23 Australia, Insulin Pumps Market, Revenue ($m),
Historic, 2002-2009 46 5.1.24 Australia, Insulin Pumps Market,
Revenue ($m), Forecast, 2009-2016 47 6 Global Insulin Pumps Market:
Strategic Competitive Assesment 48 6.1 Medtronic 49 6.1.1 Overview
49 6.2 Disetronic (Subsidiary of Roche) 50 6.2.1 Overview: 50
6.3 Animas Corporation (Subsidiary of Johnson & Johnson) 50 6.3.1
Overview: 50 6.4 Insulet Corporation 50 6.4.1 Overview 50 7
Global Insulin Pumps Market, Key Marketed Products 52 7.1 Key Insulin
Pumps in the Market 53 7.1.1 MiniMed Paradigm 522 or 722 Insulin Pump
53 7.1.2 The ACCU-CHEK Spirit insulin pump system 54 7.1.3
Accu-Chek Combo System 55 7.1.4 OneTouch Ping Insulin Pump 55
7.1.5 OmniPod Insulin Management System 56 7.1.6 Cozmo insulin pump
56 8 Global Insulin Pumps Market: Strategic Pipeline Assessment 58
8.1 Pipeline Technology Assessment 58 8.1.1 Pipeline Technology
Assessment for Insulin Pumps by Development Stage, Global 58 8.2
Profiles of Promising Products Under Clinical Development: 59 8.2.1
Artificial Pancreas System (University of Cambridge) 59 8.2.2
Disposable Insulin Pump System (NiliMEDIX) 60 8.2.3 Infusion pump (Medipacs
LLC) 60 8.2.4 Insulin and glucagon delivery system (Boston
University) 60 8.2.5 Insulin Nanopump (Debiotech S.A.) 61 8.2.6
Paradigm Veo System (Medtronic, Inc.) 62 8.2.7 Solo Insulin Patch
Pump System (Medingo Ltd.) 62 8.2.8 Solo MicroPump Insulin Delivery
System (Medingo.Ltd.) 62 9 Global Insulin Pumps Market: Strategic
Deals Analysis 65 9.1 Key Deals 65 9.1.1 Roche Holding to Acquire
Medingo From Elron Electronic Industries 65 9.1.2 Cellnovo Enters
into an Agreement with Home Diagnostics 65 9.1.3 Insulet Enters into
Distribution Agreement with Ypsomed Holding 66 9.1.4 JDRF Enters into
an Agreement with Becton, Dickinson and Company 66 9.1.5 DexCom
Amends Agreement with Animas 66 10 Appendix 68 10.1 Scope of
Pipeline Research 69 10.2 Definitions 69 10.2.1 Insulin Pumps 69
10.3 Acronyms 69 10.4 References 70 10.5 Research Methodology 70
10.6 Secondary Research 70 10.7 Primary Research 71 10.8 Models 72
10.9 Forecasts 72 10.10 Expert Panels 72 10.11 GlobalData
Consulting 72 10.12 Contact Us 73 10.13 Disclaimer 73
(managed by GlobalData)
To top
|
|
|